Maravai LifeSciences Forecast, price target & analysts
$3.25
0.00%
yesterday
Nasdaq,
Nov 12, 10:00 pm CET
Index
Industry
Maravai LifeSciences Target price 2025 - Analyst rating & recommendation
Powered by
Maravai LifeSciences Classifications & Recommendation:
Buy
59%
Hold
41%
Maravai LifeSciences Price Target
| Target Price | $4.59 |
| Price | $3.25 |
| Potential |
41.23%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Maravai LifeSciences 2026 .
The average Maravai LifeSciences target price is $4.59.
This is
41.23%
register free of charge
$5.25
61.54%
register free of charge
$2.02
37.85%
register free of charge
|
|
| A rating was issued by 17 analysts: 10 Analysts recommend Maravai LifeSciences to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Maravai LifeSciences stock has an average upside potential 2026 of
41.23%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 259.19 | 195.80 |
| 10.30% | 24.46% | |
| EBITDA Margin | -26.27% | -15.94% |
| 236.12% | 39.31% |
13 Analysts have issued a sales forecast Maravai LifeSciences 2025 . The average Maravai LifeSciences sales estimate is
$196m
Unlock
1.83%
higher
Unlock
$214m
11.13%
Unlock
$182m
5.51%
Unlock
This results in the following potential growth metrics:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.05 | -0.32 |
| 16.67% | 69.52% | |
| P/E | negative |
13 Analysts have issued a Maravai LifeSciences forecast for earnings per share. The average Maravai LifeSciences EPS is
$-0.32
Unlock
61.90%
higher
Unlock
$-0.24
71.43%
Unlock
$-0.38
54.76%
Unlock
This results in the following potential growth metrics and future valuations:
Maravai LifeSciences...
Current Maravai LifeSciences Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 12 2025 |
| Baird |
Locked
➜
Locked
|
Locked | May 13 2025 |
| Craig-Hallum |
Locked
➜
Locked
|
Locked | May 13 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Mar 03 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Feb 26 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 12 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
May 13 2025 |
|
Locked
Craig-Hallum:
Locked
➜
Locked
|
May 13 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Mar 25 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Mar 21 2025 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Mar 03 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Feb 26 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
